We are live on ! Find out more
ABC Arbitrage

ABC Arbitrage Portfolio holdings

AUM $1.02B Turnover 53.6%
1-Year Est. Return 30.46%
This Fund
S&P 500
This Quarter Est. Return
+9.79%
1 Year Est. Return
+30.46%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$876M
AUM Growth
+$337M
Cap. Flow
+$284M
Cap. Flow %
32.48%
Top 10 Hldgs %
33.79%
Holding
286
New
95
Increased
68
Reduced
35
Closed
88
Avg Time Held
0.2 years
Top 10 Avg Time Held
0.2 years
Top 20 Avg Time Held
0.3 years

Top Buys

Rank Stock Value
1
NVS icon
Novartis
NVS
+$23.5M
2
SNN icon
Smith & Nephew
SNN
+$23.2M
3
RELX icon
RELX
RELX
+$19.4M
4
BTI icon
British American Tobacco
BTI
+$17.9M
5
ERIC icon
Ericsson
ERIC
+$16.5M

Top Sells

Rank Stock Value
1
GFI icon
Gold Fields
GFI
+$12.8M
2
UL icon
Unilever
UL
+$9.06M
3
AMX icon
America Movil
AMX
+$8.86M
4
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$8.28M
5
NGG icon
National Grid
NGG
+$6.39M

Sector Composition

Rank Sector Weight
1 Healthcare 15.47%
2 Financials 14.09%
3 Technology 11.65%
4 Consumer Staples 11.48%
5 Materials 9.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ERIC icon
1
Ericsson
ERIC
$35.9B
$43.4M 4.96%
5,121,349
+2,009,723
+65% +$16.5M
2025 Q1
1 quarter
BTI icon
2
British American Tobacco
BTI
$129B
$40.8M 4.66%
862,252
+403,115
+88% +$17.9M
2024 Q4
2 quarters
VOD icon
3
Vodafone
VOD
$36.5B
$31.7M 3.62%
2,972,904
+1,598,700
+116% +$15.5M
2024 Q4
2 quarters
DEO icon
4
Diageo
DEO
$51.8B
$31.2M 3.56%
309,277
+141,195
+84% +$15.3M
2024 Q4
2 quarters
RELX icon
5
RELX
RELX
$67.7B
$30.5M 3.48%
560,958
+366,761
+189% +$19.4M
2024 Q4
2 quarters
SNN icon
6
Smith & Nephew
SNN
$12.6B
$27.5M 3.14%
898,635
+821,393
+1,063% +$23.2M
2024 Q4
2 quarters
NVS icon
7
Novartis
NVS
$298B
$25.3M 2.88%
+208,708
New +$23.5M
2025 Q2
0 quarters
RIO icon
8
Rio Tinto
RIO
$139B
$23.2M 2.65%
398,115
+118,428
+42% +$6.99M
2024 Q4
2 quarters
CUK icon
9
DELISTED
Carnival PLC
CUK
$22.8M 2.6%
893,500
+133,601
+18% +$2.59M
2024 Q4
2 quarters
PUK icon
10
Prudential
PUK
$29.4B
$19.5M 2.23%
778,900
+60,543
+8% +$1.35M
2024 Q4
2 quarters
TS icon
11
Tenaris
TS
$30.5B
$17.5M 2%
467,268
+334,755
+253% +$11.5M
2024 Q4
2 quarters
BP icon
12
BP
BP
$126B
$16.9M 1.93%
563,350
+404,088
+254% +$11.9M
2024 Q4
2 quarters
CX icon
13
Cemex
CX
$15.2B
$15.5M 1.77%
+2,235,569
New +$14.2M
2025 Q2
0 quarters
AZN icon
14
AstraZeneca
AZN
$264B
$15.3M 1.75%
109,766
-27,555
-20% -$3.86M
2025 Q1
1 quarter
MT icon
15
ArcelorMittal
MT
$46B
$14.7M 1.67%
464,169
-96,160
-17% -$2.84M
2024 Q4
2 quarters
SAP icon
16
SAP
SAP
$272B
$12.6M 1.44%
+41,448
New +$11.9M
2025 Q2
0 quarters
NWG icon
17
NatWest
NWG
$66.7B
$12.1M 1.38%
853,854
+269,839
+46% +$3.57M
2024 Q4
2 quarters
IHG icon
18
InterContinental Hotels
IHG
$24.2B
$12M 1.37%
+103,927
New +$11.7M
2025 Q2
0 quarters
NGG icon
19
National Grid
NGG
$82.2B
$11.5M 1.31%
156,765
-93,014
-37% -$6.39M
2024 Q4
2 quarters
RTO icon
20
Rentokil
RTO
$11.5B
$11M 1.26%
459,270
+406,838
+776% +$9.43M
2025 Q1
1 quarter
HLN icon
21
Haleon
HLN
$44.3B
$10.9M 1.25%
1,051,461
+1,039,425
+8,636% +$11M
2025 Q1
1 quarter
BCS icon
22
Barclays
BCS
$74.7B
$10.6M 1.21%
+570,607
New +$9.44M
2025 Q2
0 quarters
HSBC icon
23
HSBC
HSBC
$294B
$10.4M 1.19%
170,779
+120,110
+237% +$6.84M
2024 Q4
2 quarters
GMAB icon
24
Genmab
GMAB
$27.5B
$9.24M 1.05%
+447,055
New +$9.18M
2025 Q2
0 quarters
SBSW icon
25
Sibanye-Stillwater
SBSW
$6.67B
$8.09M 0.92%
+1,119,817
New +$6.12M
2025 Q2
0 quarters

Similar funds

ABC Arbitrage's Q2 2025 Portfolio in Review

As of Q2 2025, ABC Arbitrage held 286 positions worth $876M, up 63% from $538M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

ABC Arbitrage deployed $284M of net new capital in Q2 2025, opening 95 new positions and adding to 68 existing holdings. Its largest new stake was Novartis: 208,708 shares worth $25.3M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 13% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Unilever, an estimated $9.06M trimmed.

  • ABC Arbitrage's largest Q2 2025 buy was Novartis: 208,708 shares worth $25.3M.
  • ABC Arbitrage added most to Smith & Nephew in Q2 2025, an estimated $23.2M increase.
  • ABC Arbitrage's biggest Q2 2025 reduction was Unilever, cutting an estimated $9.06M.
  • ABC Arbitrage fully exited Gold Fields in Q2 2025, selling an estimated $12.8M.
  • ABC Arbitrage's ten largest holdings make up 34% of its $876M portfolio in Q2 2025.
  • ABC Arbitrage opened 95 new positions and closed 88 in Q2 2025.
  • ABC Arbitrage's portfolio value rose 63% quarter-over-quarter to $876M.

Based on ABC Arbitrage's 13F filing for Q2 2025, filed 8 Aug 2025.